Volume : 11, Issue : 01, January – 2024
Title:
ANALYZING DALFAMPRIDINE’S POTENTIAL FOR PROLONGED RELEASE AS A MATRIX TABLET USING VARIOUS GRADES OF HPMC AND EUDRAGIT
Authors :
M Ameer Khan, Niranjan Panda*, Sameera Fatima, Ayesha Farhath Fathima
Abstract :
Present studies aimed to formulate a once-daily sustained-release matrix tablet of Dalfampridine to reduce the frequency of administration and improve patient compliance. Multiple sclerosis patients who have trouble walking can benefit from dalfampridine. Dalfampridine is taken orally twice daily in doses of 10 mg, with a plasma half-life of 5.2 to 6.5 hours. A once-daily sustained-release version of dalfampridine is preferred to lessen administration frequency and boost patient compliance. BCS Class I chemical with high solubility, high permeability, and pH-independent solubility. Using hydrophilic synthetic polymers like hydroxyl propyl methyl cellulose (HPMC K4M & HPMC K15M) and hydrophobic synthetic polymers like Eudragit RSPO and RLPO, the current work sought to evaluate and improve sustained released Dalfampridine matrix tablets. To improve the release rate for a once-daily drug, a matrix tablet containing dalfampridine was created using the wet granulation process at various ratios of HPMC and Eudragit. Utilizing a USP type-II paddle type eight station dissolving device, an in vitro release investigation was carried out. To confirm the drug’s compatibility with polymers, FTIR and DSC studies were conducted. Different pre- and post-compression characterizations of the tablet were conducted, and the results complied with pharmacopeia requirements. Accelerated stability experiments were done to confirm the stability of the dosage formulations.
Key Words: Sustained release tablet, Dalfampridine, Matrix tablets, HPMC, Eudragit.
Cite This Article:
Please cite this article in press Niranjan Panda et al Analyzing Dalfampridine’s Potential For Prolonged Release As A Matrix Tablet Using Various Grades Of HPMC And Eudragit, Indo Am. J. P. Sci, 2024; 11 (01).
Number of Downloads : 10
References:
1. Jain NK. Controlled and Novel Drug Delivery, 1st edn., CBS Publishers, New Delhi, 2004;236-55.
2. Venkataramudu TS, Firoz CY, Vikram A, Divya Sree K., & Murali Krishna T; Design and characterisation sustained release matrix tablets of repaglinide using natural polymers. International Journal of Pharmaceutics. 2012; 2(2):73-83.
3. Maderuelo C, Zarzuelo A, Lanao JM. Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Release.2011; 154:2-19.
4. Naveen K. Bejugam, Helen J. Parish, and Gita N. Shankar. Influence of Formulation Factors on Tablet Formulations with Liquid Permeation Enhancer Using Factorial Design. AAPS PharmSciTech. 2009; 10 (4): 1437-1443.
5. Dey S, Mahanti B, Khila S, Mazumder B, Gupta SD; Formulation development and optimization of bilayer tablets of Aceclofenac, Expert Opin. Drug Deliv. 2012; 9(9):1041-1050.
6. Singh SK, Pandit JK, Mishra DN. Formulation and in vitro evaluation of carbopol 934P matrix tablets: Influence of drug solubility and co-excipients on release rate of the drug. J Pharm Res. 2007; 6:20-4.
7. Raval JA, Patel JK, Li N, Patel MM; Ranitidine hydrochloride floating matrix tablets based on low density powder: effects of formulation and processing parameters on drug release. Asian Journal of Pharmaceutical Sciences. 2007; 2 (4): 130-142.
8. Narendra C, Srinath MS, Babu G. Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention. AAPS PharmSciTech. 2006; 7(2):E34.
9. Islam MS, Reza S, Rahman H; In vitro Release Kinetics Study of Diltiazem Hydrochloride from Wax and Kollidon SR Based Matrix Tablets. Iranian Journal of Pharmaceutical Research 2008, 7: 101-108.
10. Panda N, Panda KC, Reddy AV, Reddy GV; Process Optimization, Formulation and Evaluation of Hydrogel {Guargum-G-Poly(Acrylamide)} Based Doxofylline Microbeads. Asian Journal of Pharmaceutical and Clinical Research, 2014 7(3), 60-65.
11. Wei He, Yongji Li, Rao Zhang, Zhannan Wu, Lifang Yin.; Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: Preparation and in vitro/in vivo evaluation. Int Jour of Pharma. 2014, 476: 223–231.
12. S. Fatima, N. Panda, AV Reddy, S Fatima “Buccal Mucoadhesive Tablets of Sumatriptan Succinate for Treatment of Sustainable Migraine:Design, Formulation and In Vitro Evaluation”Int. J. of Pharm. Res. & All. Sci. 2015;4(3):114-126
13. Patra CN, Kumar AB, Pandit HK, Singh SP, Devi MV; Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride. Acta Pharm. 2007, 57: 479-489.
14. Ali MS, Pandit V, Jain M, Dhar KL. Mucoadhesive microparticulate drug delivery system of curcumin against Helicobacter pylori infection: Design, development and optimization. J Adv Pharm Technol Res. 2014; 5: 48-56.
15. Gambhire MN, Ambade KW, Kurmi SD, Kadam VJ, Jadhav KR. Development and in vitro evaluation of an oral floating matrix tablet formulation of Diltiazem hydrochloride. AAPS PharmSciTech. 2007; 8(3):E73.
16. M. Akbar, N. Panda, AV Reddy, “Formulation and Evaluation of Doxofylline Sublingual Tablets Using Sodium Starch Glycolate and Crosscarmellose Sodium as Superdisintegrant” Int. J. of Pharm. Res. & All. Sci. 2015;4(2):90-100
17. Takka S, Rajbhandari S, Sakr A. Effect of anionic polymers on the release of Propranolol hydrochloride from matrix tablets. Eur J Pharm Biopharm. 2001; 52(1):75–82.
18. Mohd Shoukhatullah Ansari*, Afshan Sultana, Niranjan Panda, Sumayya Ather Siddiqui, Aroosa Nahid and Sana, Formulation and In Vitro Evaluation of Atorvastatin Orodispersible Tablets Using Sodium Starch Glycolate and Cross Povidone as Superdisintegrant. European Journal of Biomedical and Pharmaceutical Sciences, 2022, Volume 9, Issue 10, 322-331.
19. Mohd Shoukhatullah Ansari, Niranjan Panda, Pawan Kumar, Prabhat Kumar; Designing buccal mucoadhesive tablets of Doxofylline by using Ethocel, Carbopol 934P and Methocel K15M: A method to improve its bioavailability; Int. J. Pharm & Ind. Res., Vol.–10 (02) 2020 [61-76]
20. Basavaraja, Navade K, Rao BS, Kulkarni SV; Formulation and evaluation of sustained release matrix tablets of Flurbiprofen by using natural and synthetic polymers. J Pharm Sci Res. 2015; 7(6): 274-281.
21. Syed Arif Ahmed, Niranjan Panda*, M.S.Ansari, Afreen Kauser , Development and In vitro evaluation of acebrophylline sustained release matrix tablets employing different grade of hpmc and ethyl cellulose, 6 (3): 2716 – 2727 (2015)
22. Shiyani B; Formulation and evaluation of bilayer tablet of Metoclopramide hydrochloride and Ibuprofen. AAPS Pharm Sci Tech. 2008; 9(3):818-27.
23. Bejugam NK, Parish HJ, Shankar GN; Influence of Formulation Factors on Tablet Formulations with Liquid Permeation Enhancer Using Factorial Design. AAPS PharmSciTech. 2009; 10 (4):1437-1443.
24. Zafar R and Panda N: Formulation Design and In Vitro Evaluation of Zolmitriptan Gastroretensive Floating Matrix Tablets For Management of Migraine. Int J Pharm Sci Res 2015; 6(9): 3901-12.doi: 10.13040/IJPSR.0975-8232.6(9).3901-12.